These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 38543186)

  • 41. Solubilizing potential of submicron emulsions and aqueous dispersions of lecithin.
    Sznitowska M; Dabrowska EA; Janicki S
    Int J Pharm; 2002 Oct; 246(1-2):203-6. PubMed ID: 12270623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug-like properties and the causes of poor solubility and poor permeability.
    Lipinski CA
    J Pharmacol Toxicol Methods; 2000; 44(1):235-49. PubMed ID: 11274893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs.
    Gershanik T; Benita S
    Eur J Pharm Biopharm; 2000 Jul; 50(1):179-88. PubMed ID: 10840200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxicological properties of surfactants.
    Gloxhuber Ch
    Arch Toxicol; 1974; 32(4):245-70. PubMed ID: 4614759
    [No Abstract]   [Full Text] [Related]  

  • 45. Physicochemical characterization of a model intravenous oil-in-water emulsion.
    Westesen K; Wehler T
    J Pharm Sci; 1992 Aug; 81(8):777-86. PubMed ID: 1403723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 50years of oral lipid-based formulations: Provenance, progress and future perspectives.
    Feeney OM; Crum MF; McEvoy CL; Trevaskis NL; Williams HD; Pouton CW; Charman WN; Bergström CAS; Porter CJH
    Adv Drug Deliv Rev; 2016 Jun; 101():167-194. PubMed ID: 27089810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs.
    Vithani K; Jannin V; Pouton CW; Boyd BJ
    Adv Drug Deliv Rev; 2019 Mar; 142():16-34. PubMed ID: 30677448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vesicular phospholipid gels as drug delivery systems for small molecular weight drugs, peptides and proteins: State of the art review.
    Breitsamer M; Winter G
    Int J Pharm; 2019 Feb; 557():1-8. PubMed ID: 30572079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent Advances in Solid Dispersion Technology for Efficient Delivery of Poorly Water-Soluble Drugs.
    Paudwal G; Rawat N; Gupta R; Baldi A; Singh G; Gupta PN
    Curr Pharm Des; 2019; 25(13):1524-1535. PubMed ID: 31258070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationale utilization of phospholipid excipients: a distinctive tool for progressing state of the art in research of emerging drug carriers.
    Jebastin K; Narayanasamy D
    J Liposome Res; 2023 Mar; 33(1):1-33. PubMed ID: 35543241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.
    Pouton CW
    Eur J Pharm Sci; 2000 Oct; 11 Suppl 2():S93-8. PubMed ID: 11033431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Theory and practice of supersaturatable formulations for poorly soluble drugs.
    Kawakami K
    Ther Deliv; 2015 Mar; 6(3):339-52. PubMed ID: 25853309
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Solid State NMR Investigation for Molecular States of Specialized Formulation to Improve the Water Solubility of Poorly Water-soluble Drugs].
    Higashi K
    Yakugaku Zasshi; 2021; 141(9):1063-1069. PubMed ID: 34471007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
    Buckley ST; Frank KJ; Fricker G; Brandl M
    Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Comprehensive Insight on Recent Advancements in Self-emulsifying Drug Delivery Systems.
    Kadian R; Nanda A
    Curr Drug Deliv; 2023; 20(8):1095-1114. PubMed ID: 36111756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Retrospective Biopharmaceutical Analysis of >800 Approved Oral Drug Products: Are Drug Properties of Solid Dispersions and Lipid-Based Formulations Distinctive?
    Bennett-Lenane H; O'Shea JP; O'Driscoll CM; Griffin BT
    J Pharm Sci; 2020 Nov; 109(11):3248-3261. PubMed ID: 32822721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Palm Oil in Lipid-Based Formulations and Drug Delivery Systems.
    Efendy Goon D; Sheikh Abdul Kadir SH; Latip NA; Ab Rahim S; Mazlan M
    Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30781901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Solubility of Poorly Soluble Drugs in Phosphatidylcholine-Based Drug Delivery Systems: Comparison of the Loading Capacity in the Bulk Formulation and Its Dispersed State.
    Grüne L; Bunjes H
    Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543186
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.